A Study to Assess the Safety and Efficacy of Oral Etrasimod in Adult Participants With Eosinophilic Esophagitis (VOYAGE)
A Study to Assess the Safety and Efficacy of Oral Etrasimod in Adult Participants With Eosinophilic Esophagitis (VOYAGE)
The purpose of this study is to determine whether oral etrasimod is a safe and effective treatment for active eosinophilic esophagitis (EoE) in adult participants.
Study Type: Interventional (Clinical Trial)
Estimated Enrollment: 96 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double (Participant, Investigator)
Primary Purpose: Treatment
Official Title: A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Etrasimod in Adult Subjects With Eosinophilic Esophagitis
Actual Study Start Date: February 23, 2021
Estimated Primary Completion Date: August 2022
Estimated Study Completion Date: February 2023
Arm:
- Experimental: Etrasimod Dose 1
- Experimental: Etrasimod Dose 2
- Placebo Comparator: Placebo
| Category | Value |
|---|---|
| Study type(s) | Interventional |
| Estimated enrolment | 96 |
| Actual Study start date | 23 February 2021 |
| Estimated Study Completion Date | 01 February 2023 |